Take Home Points Forget the “traditional” needle decompression landmark Decompress at 4th or 5th intercostal space in the anterior axillary line
Background: Current management of COVID-19 focuses on supportive care as there are yet to be robust, data driven treatments. To date, there has barely been a glimmer of hope based on published evidence, as most studies are either poor quality ...
“You’re in the emergency department, you have a patient who EMS has brought in from a nursing home…who’s excited? Right, nobody is. And they are brought in for a chief complaint of altered mental status. So they’re concerned about sepsis. ...
Background: Although Helmet CPAP is not something commonly used in the US, I think its nice to know what other potential options there are to help patients in the midst of a COVID-19 pandemic. Hypoxemic acute respiratory failure (hARF) is a ...
Goals of lung protective mechanical ventilation: Minimizing harm during mechanical ventilation with a lung-protective strategy with: Low tidal volume (TV) Limit plateau pressure to <30mmHg Optimal positive end expiratory pressure (PEEP) set to decrease driving pressure
There continues to be a slew of publications coming out on a near daily basis in regard to COVID-19. Some publications will deserve their own posts and others can really be summarized in one or two paragraphs. In this post ...
Introduction: Emergency physicians rarely are involved in tube exchanges; I can’t remember the last time I had to do one. However, during the COVID19 surge, we found ourselves boarding intubated patients for days and even weeks as our ICUs were ...
The Novel Coronavirus 2019, was first reported on in Wuhan, China in late December 2019. The outbreak was declared a public health emergency of international concern in January 2020 and on March 11th, 2020, the outbreak was declared a global ...
Background: Over the past few weeks there has been a shift in the management of critically ill COVID-19 patients. Many seem to have moved away from an intubate early strategy to the use of high flow nasal cannula (HFNC) and ...
Background: Currently, there are no approved medications for the treatment of COVID-19, but, there are many investigational agents that have shown antiviral activity against SARS-CoV-2 in vitro. Unfortunately in vitro studies do not always extrapolate to clinical care In vitro ...
1 email per week. No spam.
Sponsored
© 2022 REBEL EM. All rights reserved. | Disclaimer | Website by Innov8 Place.
